mesalamine has been researched along with Fibrosis in 8 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Fibrosis: Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Skin fibrosis is a complex biological remodeling process occurring in disease like systemic sclerosis, morphea, or eosinophilic fasciitis." | 1.62 | Systemic mesalazine treatment prevents spontaneous skin fibrosis in PLK2-deficient mice. ( Günther, C; Hoffmann, M; Kant, TA; Klapproth, E; Künzel, K; Künzel, SR; Newe, M; Rausch, JSE; Winter, L, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Hoffmann, M | 3 |
| Kant, TA | 2 |
| Emig, R | 1 |
| Rausch, JSE | 3 |
| Newe, M | 2 |
| Schubert, M | 1 |
| Künzel, K | 3 |
| Winter, L | 2 |
| Klapproth, E | 3 |
| Peyronnet, R | 1 |
| Ravens, U | 2 |
| El-Armouche, A | 2 |
| Künzel, SR | 3 |
| Günther, C | 1 |
| Weber, S | 1 |
| Kämmerer, S | 1 |
| Günscht, M | 1 |
| Sadek, MS | 1 |
| Kolanowski, T | 1 |
| Meyer-Roxlau, S | 1 |
| Piorkowski, C | 1 |
| Tugtekin, SM | 1 |
| Rose-John, S | 1 |
| Yin, X | 1 |
| Mayr, M | 1 |
| Kuhlmann, JD | 1 |
| Wimberger, P | 1 |
| Grützmann, K | 1 |
| Herzog, N | 1 |
| Küpper, JH | 1 |
| O'Reilly, M | 1 |
| Kabir, SN | 1 |
| Sommerfeld, LC | 1 |
| Guan, K | 1 |
| Wielockx, B | 1 |
| Fabritz, L | 1 |
| Nattel, S | 1 |
| Dobrev, D | 1 |
| Wagner, M | 1 |
| Prado Mel, E | 1 |
| Gil López, M | 1 |
| Prieto, G | 1 |
| Pérez-Moneo, B | 1 |
| Molina, M | 1 |
| Ramos, E | 1 |
| Sarría, J | 1 |
| Larrauri, J | 1 |
| Tovar, JA | 1 |
| Borum, ML | 1 |
| Ginsberg, AL | 1 |
| Allgayer, H | 1 |
| Böhne, P | 1 |
| Kruis, W | 1 |
| Gaia, E | 1 |
| Sambatoro, A | 1 |
| De Giuli, P | 1 |
| Angeli, A | 1 |
8 other studies available for mesalamine and Fibrosis
| Article | Year |
|---|---|
Repurposing mesalazine against cardiac fibrosis in vitro.
Topics: Actins; Cardiotonic Agents; Cell Differentiation; Cell Line; Collagen Type I; Drug Repositioning; Ex | 2021 |
Systemic mesalazine treatment prevents spontaneous skin fibrosis in PLK2-deficient mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Differentiation; Collagen; Creatinine; Diseas | 2021 |
Diminished PLK2 Induces Cardiac Fibrosis and Promotes Atrial Fibrillation.
Topics: Aged; Animals; Atrial Fibrillation; Cells, Cultured; Female; Fibrosis; Humans; Male; Mesalamine; Mic | 2021 |
[Mesalazine-induced intersticial pneumonitis in patients with ulcerative colitis].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Fibrosis; Humans; Lung Diseases, Inter | 2016 |
Fibrosing colonopathy associated with treatment with enteric-coated mesalazine pills.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Child; Colitis, Ulcerative; Colon; Colonoscopy; Fibrosis; H | 2009 |
Lack of evidence for fibrosing colonopathy by 5-ASA in humans.
Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Colitis; Fibrosis; Humans; Intestinal | 1999 |
Drug-induced fibrosing colonopathy in inflammatory bowel disease after 5-ASA?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Colonic Diseases; Fibrosis; Humans; Mesalamine; Proctocolit | 1999 |
Adult fibrosing colonopathy associated with mesalazine treatment.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Colonic Diseases; Female; Fibrosis; Humans; Mesalamine; Mid | 2001 |